Inivata Ltd - Product Pipeline Analysis, 2019 Update

Inivata Ltd - Product Pipeline Analysis, 2019 Update

Summary

Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotide variants, insertions and deletions and structural variants in selected genes from DNA isolated from plasma samples from patients with non-small cell lung cancer; and InVisionSeq test. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctDNA analysis. The company operates in the UK and the US. Inivata is headquartered in Cambridge, Cambridgeshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Inivata Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Inivata Ltd Company Overview
Inivata Ltd Company Snapshot
Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview
Inivata Ltd – Pipeline Analysis Overview
Inivata Ltd - Key Facts
Inivata Ltd - Major Products and Services
Inivata Ltd Pipeline Products by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd Pipeline Products Overview
InVision ctDNA Assay - EGFR-Mutant NSCLC
InVision ctDNA Assay - EGFR-Mutant NSCLC Product Overview
InVision ctDNA Assay - Metastatic Breast Cancer
InVision ctDNA Assay - Metastatic Breast Cancer Product Overview
InVision ctDNA Assay - NSCLC
InVision ctDNA Assay - NSCLC Product Overview
InVision ctDNA Assay - NSCLC Clinical Trial
InVision ctDNA Assay - Pancreatic Cancer
InVision ctDNA Assay - Pancreatic Cancer Product Overview
InVision ctDNA Assay - Stage III/IV NSCLC
InVision ctDNA Assay - Stage III/IV NSCLC Product Overview
InVision First - Lung
InVision First - Lung Product Overview
InVision First - Lung Clinical Trial
Inivata Ltd - Key Competitors
Inivata Ltd - Key Employees
Inivata Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Inivata Ltd, Recent Developments
Aug 12, 2019: Inivata appoints Jacqui Watson as Chief People Officer
Jul 18, 2019: Inivata announces launch of clinical trial to evaluate impact of InVisionFirst-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
Apr 26, 2019: Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst-Lung liquid biopsy test
Apr 16, 2019: Genomics England and industry partners complete first phase of liquid biopsy study
Mar 07, 2019: Inivata publishes positive results of clinical validation and utility study for InVision Liquid Biopsy Test
Mar 05, 2019: Inivata receives medicare final coverage decision for InVisionFirst-Lung Liquid Biopsy test in advanced Non-Small Cell Lung Cancer
Dec 20, 2018: Inivata names Charlie Kesinger as Chief Information Officer
Sep 24, 2018: Inivata to Present Results of Prospective Clinical Validation Study of its InVisionFirst-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer at the World Conference on Lung Cancer
Sep 13, 2018: Inivata achieves major milestone with draft medicare local coverage determination (LCD) for InVisionFirst-lung liquid biopsy test
Sep 12, 2018: Inivata announces senior management change
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview
Inivata Ltd Pipeline Products by Equipment Type
Inivata Ltd Pipeline Products by Indication
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd, Key Facts
Inivata Ltd, Major Products and Services
Inivata Ltd Number of Pipeline Products by Development Stage
Inivata Ltd Pipeline Products Summary by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd Ongoing Clinical Trials Summary
InVision ctDNA Assay - EGFR-Mutant NSCLC - Product Status
InVision ctDNA Assay - EGFR-Mutant NSCLC - Product Description
InVision ctDNA Assay - Metastatic Breast Cancer - Product Status
InVision ctDNA Assay - Metastatic Breast Cancer - Product Description
InVision ctDNA Assay - NSCLC - Product Status
InVision ctDNA Assay - NSCLC - Product Description
InVision ctDNA Assay - NSCLC - Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI
InVision ctDNA Assay - Pancreatic Cancer - Product Status
InVision ctDNA Assay - Pancreatic Cancer - Product Description
InVision ctDNA Assay - Stage III/IV NSCLC - Product Status
InVision ctDNA Assay - Stage III/IV NSCLC - Product Description
InVision First - Lung - Product Status
InVision First - Lung - Product Description
InVision First - Lung - A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients with Suspicious Metastatic Lung Cancer
InVision First - Lung - Analytical Validation of a Next Generation Sequencing Liquid Biopsy Assay for High Sensitivity Broad Molecular Profiling
InVision First - Lung - Evaluation of Liquid Biopsies for Molecular Profiling in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) in the Relapse Treatment Setting
Inivata Ltd, Key Employees
Glossary
List of Figures
Inivata Ltd Pipeline Products by Equipment Type
Inivata Ltd Pipeline Products by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook